Fast Market Research

Now Available: Nordmark Arzneimittel GmbH & Co. KG - Product Pipeline Review - 2014

Recently published research from Global Markets Direct, "Nordmark Arzneimittel GmbH & Co. KG - Product Pipeline Review - 2014", is now available at Fast Market Research

 

Boston, MA -- (ReleaseWire) -- 03/03/2014 -- Global Market Direct's pharmaceuticals report, "Nordmark Arzneimittel GmbH & Co. KG - Product Pipeline Review - 2014" provides data on the Nordmark Arzneimittel GmbH & Co. KG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Nordmark Arzneimittel GmbH & Co. KG's corporate website, SEC filings, investor presentations and featured press releases, both from Nordmark Arzneimittel GmbH & Co. KG and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Report Scope

- Nordmark Arzneimittel GmbH & Co. KG - Brief Nordmark Arzneimittel GmbH & Co. KG overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Nordmark Arzneimittel GmbH & Co. KG human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Nordmark Arzneimittel GmbH & Co. KG with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Nordmark Arzneimittel GmbH & Co. KG's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get this Report

- Evaluate Nordmark Arzneimittel GmbH & Co. KG's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Nordmark Arzneimittel GmbH & Co. KG in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Nordmark Arzneimittel GmbH & Co. KG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Nordmark Arzneimittel GmbH & Co. KG.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Nordmark Arzneimittel GmbH & Co. KG and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- AiCuris GmbH & Co. KG - Product Pipeline Review - 2013
- Isarna Therapeutics GmbH - Product Pipeline Review - 2014
- Nordmark Arzneimittel GmbH & Co. KG - Strategic SWOT Analysis Review
- sterna biologicals Gmbh & Co KG - Product Pipeline Review - 2013
- Dr. Falk Pharma GmbH - Product Pipeline Review - 2013
- Boehringer Ingelheim GmbH - Product Pipeline Review - 2013
- Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2014
- Genzyme Corporation - Product Pipeline Review - 2014
- CSL Limited - Product Pipeline Review - 2014
- Array BioPharma Inc. - Product Pipeline Review - 2014